We are thrilled to announce that our very own Brett Alderson, President and Site Leader of NovaCina, was recently featured on the Molecule to Market podcast hosted by Raman Sehgal. In this engaging episode, Brett delves into becoming a CDMO within the global drug development sector, providing valuable insights and expertise.

During the podcast, Brett and Raman explore various aspects of the pharmaceutical industry including the complexities of transitioning from big pharma to a customer-facing Contract Development and Manufacturing Organisation (CDMO) like NovaCina. They also discuss the freedom and liberation that comes with being an independent business, as well as NovaCina’s unique approach of combining world-class commercial capabilities with a focus on smaller-scale clinical offerings.

Brett’s extensive experience in the pharmaceutical industry, particularly in manufacturing Sterile Injectables, shines through as he shares his journey and leadership philosophy. He is known for his determination, thoughtful leadership style, and dedication to driving business success while championing a customer-centric culture at NovaCina.

Having spent over 25 years at Pfizer before joining NovaCina in April 2023, Brett has been instrumental in overseeing a 400-member team and the production of a diverse range of pharmaceutical products, including over 300 Oncology products and various sterile injectable medicines for both local and global markets.

We invite you to listen to this insightful episode of Molecule to Market featuring Brett Alderson, where he discusses industry trends, challenges, and the exciting future of drug development at NovaCina. Stay tuned for more updates and news from NovaCina as we continue to innovate and lead in the pharmaceutical industry!

From Pfizer to CDMO carve-out – Molecule to Market (moleculetomarketpod.com)

Episode links
🎧 Apple Podcast
🎧 Amazon
🎧 Spotify

#moleculetomarket #podcast #pharmapodcast #lifesciences #pharmaceuticals #CDMO